Abstract Purpose of Review In France, in order to describe the phenotypic characteristics of
patients with diabetes hospitalized for coronavirus disease-2019 (COVID-19) and to identify …

Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

The novel severe acute respiratory distress syndrome-coronavirus 2 (SARS-CoV-2) has
caused one of the most substantial pandemics that has affected humanity in the last century …

Purpose While obesity is related to more severe outcomes of coronavirus disease 2019
(COVID-19), factors leading to poor prognosis still remain unclear. The present study …

Introduction To investigate the effect of preexisting treatment with dipeptidyl peptidase-4
inhibitors (DPP-4is) on COVID-19-related hospitalization and mortality in patients with type 2 …

Obesity is a risk factor for severe respiratory diseases, including COVID-19 infection. Meta-
analyses on mortality risk were inconsistent. We systematically searched 3 databases …

Background: COVID-19 is a disease caused by a new coronavirus called SARS-CoV-2. In
more severe cases, COVID-19 can cause death. The most severe COVID-19 patient …

Purpose New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with
diabetes. However, there are insufficient data about the effect of hyperglycemia on COVID …

Abstract Background Since December 2019, the world has struggled with the COVID‐19
pandemic. Even after the introduction of various vaccines, this disease still takes a …